
Emsyl 250mg/250mg Injection
Marketer
Shrinivas Gujarat Laboratories Pvt Ltd
Salt Composition
Tranexamic Acid (250mg) + Ethamsylate (250mg)
Overview Emsyl 250mg/250mg Injection
Tranexamic acid/another active ingredient 250mg/250mg injection treats excessive menstrual bleeding. Its mechanism involves inhibiting fibrinolysis (blood clot breakdown), thus reducing bleeding. This effect is augmented by enhanced platelet aggregation. Administration is strictly by injection under medical supervision, continuing as directed. Follow prescribed dosage and duration; missed doses should be taken immediately upon recall. Complete the entire course, regardless of symptom improvement; abrupt cessation requires prior physician consultation. Common side effects may encompass nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is recommended to mitigate dehydration. Prior to commencing treatment, inform your physician of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or concurrent medications. Regular eye examinations may be necessary during treatment.
Uses of Emsyl 250mg/250mg Injection
Profuse uterine bleeding
Major Benefits of Emsyl 250mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Emsyl 250mg/250mg Injection:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use Emsyl 250mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Emsyl 250mg/250mg Injection works:
Emsyl 250mg/250mg Injection combines Tranexamic Acid and Ethamsylate to manage hemorrhage. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, thereby reducing excessive blood loss. Ethamsylate, a hemostatic medication, enhances platelet aggregation and clot formation, also controlling bleeding from small capillaries.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Emsyl 250mg/250mg Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the administration of Emsyl 250mg/250mg Injection to pregnant individuals is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Emsyl 250mg/250mg Injection with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Administering Emsyl 250mg/250mg Injection typically does not impair driving ability.
KidneyCAUTION
Caution is advised when administering Emsyl 250mg/250mg Injection to individuals with impaired renal function. Dosage modification for Emsyl 250mg/250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Emsyl 250mg/250mg Injection in patients with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification for Emsyl 250mg/250mg Injection may be unnecessary in this population; however, medical advice is recommended.
What if you forget to take Emsyl 250mg/250mg Injection :
Omit a scheduled Emsyl 250mg/250mg Injection? Seek immediate medical advice.
Facts to Know About Emsyl 250mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
